Lineage Cell Therapeutics, Inc.: accounts_receivable

Value{"amount": 638000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"}
Period (as of 2024-12-31)
Statuscurrent
EntityLineage Cell Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-25-036309 · Open the official SEC filing →
Retrieved: 2026-08-19T08:43:18.575078+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000876343/accounts-receivable/2024-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/89cf43ff-0403-4e4a-a9f0-eb276ae93e78

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies